| ESWT | ESBBT | ESNHPT |
---|---|---|---|
Sample size | 4 | 9 | 13 |
SMA type | Â | Â | Â |
2 | 0 | 3 | 6 |
3a | 1 | 3 | 4 |
3b | 3 | 3 | 3 |
Age | Â | Â | Â |
yrs (min.-max.) | 26.2 (10–37) | 20.8 (10–37) | 23.9 (10–49) |
Gender | Â | Â | Â |
Male | 2 | 6 | 8 |
Female | 1 | 3 | 5 |
HFMSE | Â | Â | Â |
0–66 | 52 (44–66) | 31 (4–66) | 22 (1–66) |
Time to Limitation | Â | Â | Â |
0–600 | 555 (462–600) | 373 (83–600) | 457 (52–600) |
Reduced time to limitation | Â | Â | Â |
Yes | 50% | 44,4% | 30,8% |
No | 50% | 55,6% | 69,2% |
Measurement completion | Â | Â | Â |
Yes | 100% | 100% | 100% |
No | 0% | 0% | 0% |
Comprehensibility | Â | Â | Â |
Yes | 100% | 100% | 100% |
No | 0% | 0% | 0% |
Acceptability | Â | Â | Â |
0–10 (min. – max.) | 9.2 (7.4–10) | 9.6 (7.9–10) | 8.9 (4.9–10) |
Perceived burden | Â | Â | Â |
Muscle fatigue | 7 (6–9) | 4.9 (3–9) | 4.5 (1–10) |